The Leprosy Mission's recent research publications
We are pleased to share three papers and one pre-print from the Transforming the Treatment and Prevention of Leprosy and Buruli ulcers in Low and Middle-Income Countries (LMICs) study.
This research was funded by the National Institute for Health Research (NIHR: 200132) using UK Aid from the UK Government to support global health research.
Darlong J, Govindasamy K, Ilozumba O, Choudhury S, Shrivastva A, Griffiths F, et al. (2023) An evaluation protocol of ‘Replicability Model’ project for detection and treatment of leprosy and related disability in Chhattisgarh, India. PLoS ONE 18(10): e0275763. https://doi.org/10.1371/journal.pone.0275763
Choudhury S, Ilozumba O, Darlong J, et al. Investigating the sustainability of self- help programmes in the context of leprosy and the work of leprosy missions in Nigeria, Nepal and India: a qualitative study protocol. BMJ Open 2023;13:e070604. doi:10.1136/ bmjopen-2022-070604
Govindasamy, K., Darlong, J., Watson, S.I. et al. Prevalence of plantar ulcer and its risk factors in leprosy: a systematic review and meta-analysis. J Foot Ankle Res 16, 77 (2023). https://doi.org/10.1186/s13047-023-00674-4
PRE-PRINT: Honey Experiment on LeProsy Ulcer (HELP) Study Protocol: A Randomised Control Trial of Raw, Unadulterated African Honey for Ulcer Healing in Leprosy: A Study Protocol Sunday Odihiri Udo, Pius Ogbu Sunday, Paul Alumbugu Tsaku, Israel Olaoluwa Oladejo, Anthony Meka, Linda Ugwu, Motunrayo Ajisola, Joshua Akinyemi, Akinyinka Omigbodun, Sopna Choudhury, Jo Sartori, Onaedo Ilozumba, Samuel I. Watson, Richard J Lilford doi: https://doi.org/10.1101/2023.07.14.23292603
The Leprosy Mission Trust India and ICMR have also published a paper demonstrating viable M. Leprae after 12 months MDT:
Singh I, Ahuja M, Lavania M, Pathak VK, Turankar RP, Singh V, et al. Efficacy of fixed duration multidrug therapy for the treatment of multibacillary leprosy: A prospective observational study from Northern India. Indian J Dermatol Venereol Leprol 2023;89:226-32.
This year, LRI has announced two calls for proposals for budget round 2025; the regular grant and the new RESILIENTD grant, in collaboration with Anesvad Foundation.
The Leprosy Research Initiative (LRI) is pleased to announce the annual call for proposals for funding commencing in 2024. LRI funds research with a focus on leprosy – including research applications combining leprosy with other neglected tropical diseases (NTDs) or other diseases or disabilities that share cross-cutting issues with leprosy.
Researchers interested to apply for funding by the LRI are invited to complete and submit a Letter of Intent (LoI), giving an outline of the intended research.
Letters of Intent should be submitted by Friday 26 January 2024 at 23:59 (CET) after which the application portal will be closed.
Learn more here >
The Leprosy Research Initiative (LRI) is pleased to announce a new call for proposals for funding commencing in 2025. In collaboration with the Anesvad Foundation, LRI invites research proposals on the social determinants of health in the context of skin neglected tropical diseases (NTDs) including leprosy, with a focus on Sub-Saharan Africa.
Researchers interested to apply for RESILIENTD grant funding are invited to complete and submit a Letter of Intent (LoI), giving an outline of the intended research.
LoIs should be submitted by Friday 26 January 2024 at 23:59 (CET) after which the application portal will be closed.